Description
C2B8 (Rituximab) is a chimeric mouse/human monoclonal antibody (mAb) directed against the human B cell-restricted cell surface antigen CD20. It might be a potent antibody to used in the treatment study of B cell non-Hodgkin lymphomas (NHL).
Target
MS4A1
Target Alias Names
B1, S7, Bp35, CD20, CVID5, LEU-16
Isotype/Mimetic
Chimeric (mouse/human) IgG1
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression